Marc Alan Pfeffer
Impact in
- Cardiology and Cardiovascular Medicine top 0.01%
- Heart Failure Treatment and Management
- Cardiovascular Function and Risk Factors
- Blood Pressure and Hypertension Studies
- Cardiac pacing and defibrillation studies
- Acute Myocardial Infarction Research
- Endocrinology, Diabetes and Metabolism top 0.01%
- Diabetes Treatment and Management
Papers in
-
- Heart Failure Treatment and Management 188
- Cardiovascular Function and Risk Factors 137
- Blood Pressure and Hypertension Studies 46
- Acute Myocardial Infarction Research 32
- Cardiac pacing and defibrillation studies 31
-
- Hormonal Regulation and Hypertension 30
- Co-authors
- John J.V. McMurray (251 shared papers)Eugene Braunwald (48 shared papers)Scott David Solomon (251 shared papers)Eugene Braunwald (39 shared papers)Jean Lucien Rouleau (113 shared papers)Karl B Swedberg (82 shared papers)Salim Yusuf (71 shared papers)Frank M. Sacks (33 shared papers)
- Journals
- Circulation (86 papers)Journal of the American College of Cardiology (79 papers)European Journal of Heart Failure (68 papers)American Heart Journal (40 papers)New England Journal of Medicine (36 papers)
- Partner nations
- United StatesUnited KingdomCanada
In The Last Decade
Marc Alan Pfeffer
699 papers receiving 117.3k citations
Marc Alan Pfeffer's Hit Papers
Peers
Comparison fields: 5 of 199
- Cardiology and Cardiovascular Medicine 64.3k
- Endocrinology, Diabetes and Metabolism 18.0k
- Nephrology 7.8k
- Surgery 23.7k
- Family Practice 607
Countries citing papers authored by Marc Alan Pfeffer
This map shows the geographic impact of Marc Alan Pfeffer's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Marc Alan Pfeffer with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Marc Alan Pfeffer more than expected).
Fields of papers citing papers by Marc Alan Pfeffer
This network shows the impact of papers produced by Marc Alan Pfeffer. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Marc Alan Pfeffer. The network helps show where Marc Alan Pfeffer may publish in the future.
Co-authors
The 25 scholars most cited alongside Marc Alan Pfeffer, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 717 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | The Effect of Pravastatin on Coronary Events after Myocardial Infarction in Patients with Average Cholesterol Levels Hit paper breakdown → | 1996 | 6130 |
| 2 | Effect of Captopril on Mortality and Morbidity in Patients with Left Ventricular Dysfunction after Myocardial Infarction Hit paper breakdown → | 1992 | 4840 |
| 3 | Intensive versus Moderate Lipid Lowering with Statins after Acute Coronary Syndromes Hit paper breakdown → | 2004 | 3947 |
| 4 | Kidney Disease as a Risk Factor for Development of Cardiovascular Disease Hit paper breakdown → | 2003 | 3180 |
| 5 | Ventricular remodeling after myocardial infarction. Experimental observations and clinical implications. Hit paper breakdown → | 1990 | 2424 |
| 6 | Cardiac-Resynchronization Therapy for the Prevention of Heart-Failure Events Hit paper breakdown → | 2009 | 2394 |
| 7 | Effects of candesartan in patients with chronic heart failure and preserved left-ventricular ejection fraction: the CHARM-Preserved Trial Hit paper breakdown → | 2003 | 2364 |
| 8 | Spironolactone for Heart Failure with Preserved Ejection Fraction Hit paper breakdown → | 2014 | 2170 |
| 9 | Effects of candesartan in patients with chronic heart failure and reduced left-ventricular systolic function taking angiotensin-converting-enzyme inhibitors: the CHARM-Added trial Hit paper breakdown → | 2003 | 2025 |
| 10 | Valsartan, Captopril, or Both in Myocardial Infarction Complicated by Heart Failure, Left Ventricular Dysfunction, or Both Hit paper breakdown → | 2003 | 1944 |
| 11 | Lixisenatide in Patients with Type 2 Diabetes and Acute Coronary Syndrome Hit paper breakdown → | 2015 | 1926 |
| 12 | C-Reactive Protein Levels and Outcomes after Statin Therapy Hit paper breakdown → | 2005 | 1898 |
| 13 | Angiotensin–Neprilysin Inhibition in Heart Failure with Preserved Ejection Fraction Hit paper breakdown → | 2019 | 1835 |
| 14 | AHA/ACC Guidelines for Secondary Prevention for Patients With Coronary and Other Atherosclerotic Vascular Disease: 2006 Update Hit paper breakdown → | 2006 | 1759 |
| 15 | Cardiovascular Risk Associated with Celecoxib in a Clinical Trial for Colorectal Adenoma Prevention Hit paper breakdown → | 2005 | 1726 |
| 16 | A Trial of Darbepoetin Alfa in Type 2 Diabetes and Chronic Kidney Disease Hit paper breakdown → | 2009 | 1657 |
| 17 | Relation between Renal Dysfunction and Cardiovascular Outcomes after Myocardial Infarction Hit paper breakdown → | 2004 | 1631 |
| 18 | Renin–Angiotensin–Aldosterone System Inhibitors in Patients with Covid-19 Hit paper breakdown → | 2020 | 1619 |
| 19 | Effects of candesartan on mortality and morbidity in patients with chronic heart failure: the CHARM-Overall programme Hit paper breakdown → | 2003 | 1497 |
| 20 | Effects of candesartan in patients with chronic heart failure and reduced left-ventricular systolic function intolerant to angiotensin-converting-enzyme inhibitors: the CHARM-Alternative trial Hit paper breakdown → | 2003 | 1311 |
About Marc Alan Pfeffer
Marc Alan Pfeffer is a scholar working on Cardiology and Cardiovascular Medicine, Endocrinology, Diabetes and Metabolism, Nephrology, Surgery and Hematology, having authored 717 papers that have together received 125.3k indexed citations. Recurring topics across this work include Heart Failure Treatment and Management (188 papers), Cardiovascular Function and Risk Factors (137 papers), Lipoproteins and Cardiovascular Health (47 papers), Blood Pressure and Hypertension Studies (46 papers), Cardiac Imaging and Diagnostics (36 papers), Acute Myocardial Infarction Research (32 papers), Cardiac pacing and defibrillation studies (31 papers) and Hormonal Regulation and Hypertension (30 papers). The work is most often cited by research in Cardiology and Cardiovascular Medicine (64.3k citations), Endocrinology, Diabetes and Metabolism (18.0k citations), Nephrology (7.8k citations), Surgery (23.7k citations) and Family Practice (607 citations). Marc Alan Pfeffer has collaborated with scholars based in United States, United Kingdom and Canada. Frequent co-authors include John J.V. McMurray, Eugene Braunwald, Scott David Solomon, Eugene Braunwald, Jean Lucien Rouleau, Karl B Swedberg, Salim Yusuf, Frank M. Sacks, Lemuel A. Moyé and Christopher Bull Granger. Their work appears in journals such as Circulation, Journal of the American College of Cardiology, European Journal of Heart Failure, American Heart Journal and New England Journal of Medicine.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.